INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
115.1K sh
Apr 15, 2026Apr 15, 2026
Page 964 of 1737
← PrevNext →
traded Apr 15, 2026
+0d
SEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
550 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
111.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
4,000 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
Siebel Thomas MDirector, Executive Chairman, 10% Owner
AIC3.ai, Inc.
Option exercise · 10b5-1 plan
M$665K
326.2K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
MG
Merrill GaryChief Financial Officer
CVLTCOMMVAULT SYSTEMS INC
Grant or award
A—
12.3K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
HR
Haines John RSenior Exec Vice President
CELUCelularity Inc
Option exercise
M—
1,641 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
BS
Brigido StephenPres., Functional Regeneration
CELUCelularity Inc
Option exercise
M—
821 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
GW
Geissler WernerDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Tax withholding
F$32K
4,572 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
51.2K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
MA
McGinnis Christopher ASee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
37.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,018 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
HC
Hing ChristiCHIEF ACCOUNTING OFFICER
STKSONE Group Hospitality, Inc.
Tax withholding
F$11K
5,590 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

13
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
4,000 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

13
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$373K
14.1K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

13
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
155 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

12
GR
Gingras Christopher RaymondDirector
MDVMODIV INDUSTRIAL, INC.
Other acquisition or disposition
J$541
35 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
SW
Saak Aaron WDirector
AOSSMITH A O CORP
Grant or award
A$150K
2,262 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

12
WM
Wessel MichaelDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Grant or award
A$180K
25.6K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

12
MC
Morris Philip CDirector
AROWARROW FINANCIAL CORP
Other acquisition or disposition
J$1,017
28 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

12
GR
Gingras Christopher RaymondDirector
MDVMODIV INDUSTRIAL, INC.
Other acquisition or disposition
J$1,075
43 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
SM
Showalter Christopher MichaelChief Executive Officer
LZMLifezone Metals Ltd
Tax withholding
F$183K
46.5K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

12
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$626K
30.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
LC
Lee David ChGeneral Counsel & Secretary
TPHTri Pointe Homes, Inc.
Gift
G—
3,400 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
BG
Bexiga Annabelle GDirector
SNEXStoneX Group Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,500 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

12
SK
Siu Hera KDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Grant or award
A$180K
25.6K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

11
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$353K
7,921 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

10
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$176K
6,348 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

9
FJ
Feltheimer JonDirector, Chief Executive Officer
LIONLionsgate Studios Corp.
Grant or award
A—
4.50M sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
HR
Haines John RSenior Exec Vice President
CELUCelularity Inc
Option exercise
M—
1,641 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
MD
Muzzey DaleChief Scientific Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$4,645
946 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
MG
Macomber Sasha G.Chief Human Resource Officer
RWTREDWOOD TRUST INC
Option exercise
M—
8,031 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
BS
Brigido StephenPres., Functional Regeneration
CELUCelularity Inc
Option exercise
M—
821 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
TS
Taecker Benjamin S.Chief Eng and Opr Officer
AQMSAqua Metals, Inc.
Tax withholding
F$2,803
715 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
WE
West EricChief Financial Officer
AQMSAqua Metals, Inc.
Tax withholding
F$3,383
863 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
WR
Wahlund Todd RSenior Vice President
OTTROtter Tail Corp
Grant or award
A—
300 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
SK
Siu Hera KDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Option exercise
M—
9,523 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
AJ
Abate Christopher JDirector, Chief Executive Officer
RWTREDWOOD TRUST INC
Option exercise
M—
51.4K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

9
SK
Siu Hera KDirector
GTGOODYEAR TIRE & RUBBER CO /OH/
Option exercise
M—
9,523 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

9
NJ
Nelson Tyler JVP, Chief Financial Officer
OTTROtter Tail Corp
Grant or award
A—
800 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence